Showing 1 - 4 results of 4 for search 'L. Eliason', query time: 0.02s
Refine Results
-
1
-
2
PB2022: EXPLORING ALTERNATIVE DOSING REGIMENS OF SINGLE-AGENT BELANTAMAB MAFODOTIN ON SAFETY AND EFFICACY IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: DREAMM-14 by M. Hultcrantz, D. Kleinman, P. Ghataorhe, A. Mckeown, W. He, T. Ling, R. C. Jewell, J. Byrne, L. Eliason, E. Scott, J. Opalinska
Published 2022-06-01
Article -
3
Aortoenteric fistulae temporization and treatment: lessons learned from a multidisciplinary approach to 3 patients by Jeffrey Forris Beecham Chick, MD, MPH, DABR, Jordan C. Castle, MD, Kyle J. Cooper, MD, Ravi N. Srinivasa, MD, Jonathan L. Eliason, MD, Nicholas H. Osborne, MD, Karen M. Kim, MD, Wael E. Saad, MBBCh, FSIR, Minhaj S. Khaja, MD, MBA
Published 2017-06-01
Article -
4
P13: CAN PATIENT-REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING BELANTAMAB MAFODOTIN? by R Popat, A Badros, S Kumar, P Rodriguez-Otero, A Cohen, S Manier, P Voorhees, F Gay, R Rifkin, T Martin, A Chari, K Weisel, A Farooq, B Jeng, W Chng, H Lee, J Berdeja, V Jadhav, A Tosolini, L Eliason, A Palumbo, M Dimopoulos, S Lonial, S Trudel, P Richardson, E Terpos
Published 2022-04-01
Article